ERBB2 and cancer: Immunocompromised athymic nude mice were implanted with GFP-HER2-BM human cancer cells in mammary fat pads and treated with vehicle or 30 mg/kg BW EHop-016 by intraperitoneal (IP) route 3 times a week for 55 days.